| Net Cash Provided by (Used in) Operating Activities |
$426,000,000 |
USD |
130% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$15,435,000,000 |
USD |
-15% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$16,715,000,000 |
USD |
-2.1% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$851,000,000 |
USD |
-142% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$16,895,000,000 |
USD |
18% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$197,000,000 |
USD |
310% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$6,397,000,000 |
USD |
-15% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$5,535,000,000 |
USD |
55% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$318,000,000 |
USD |
26% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
200,000 |
shares |
|
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$19,238,000,000 |
USD |
-1.8% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$6,200,000,000 |
USD |
-17% |
Q4 2025 |
FY 2025 |